60 related articles for article (PubMed ID: 16553185)
1. Longitudinal trends in cervical cytological lesions and the effect of risk factors. A 30-year overview.
Sigurdsson K; Sigvaldason H
Acta Obstet Gynecol Scand; 2006; 85(3):350-8. PubMed ID: 16553185
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal trends in cervical histological lesions (CIN 2-3+): a 25-year overview.
Sigurdsson K; Sigvaldason H
Acta Obstet Gynecol Scand; 2006; 85(3):359-65. PubMed ID: 16553186
[TBL] [Abstract][Full Text] [Related]
3. [Are analyses of cytological cervix smears from young women more harmful than beneficial?].
Skjeldestad FE; Hagen B; Hagmar B; Iversen OE; Juvkam KH; Steen R; Thoresen S; Hareide B
Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1782-5. PubMed ID: 17599128
[TBL] [Abstract][Full Text] [Related]
4. [Cervical smears: towards an optimal screening for cervical cancer].
Leroy JL; Boman F
Presse Med; 2003 Feb; 32(4):174-80. PubMed ID: 12610474
[TBL] [Abstract][Full Text] [Related]
5. Risk variables affecting high-grade Pap smears at second visit: effects of screening interval, year, age and low-grade smears.
Sigurdsson K; Adalsteinsson S
Int J Cancer; 2001 Dec; 94(6):884-8. PubMed ID: 11745493
[TBL] [Abstract][Full Text] [Related]
6. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer screening in a rural population of Zimbabwe.
Thistle PJ; Chirenje ZM
Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of cytological screening for cancers and precancerous lesions of the cervix].
Boman F; Duhamel A; Trinh QD; Deken V; Leroy JL; Beuscart R
Bull Cancer; 2003 Jul; 90(7):643-7. PubMed ID: 12957806
[TBL] [Abstract][Full Text] [Related]
9. Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964-1991.
Sigurdsson K
Int J Cancer; 1993 Jun; 54(4):563-70. PubMed ID: 8514448
[TBL] [Abstract][Full Text] [Related]
10. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
[TBL] [Abstract][Full Text] [Related]
11. Trends in cervical intra-epithelial neoplasia in Iceland through 1995: evaluation of targeted age groups and screening intervals.
Sigurdsson K
Acta Obstet Gynecol Scand; 1999 Jul; 78(6):486-92. PubMed ID: 10376857
[TBL] [Abstract][Full Text] [Related]
12. Risk of cervical cancer after a negative Pap smear.
Viikki M; Pukkala E; Hakama M
J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
[TBL] [Abstract][Full Text] [Related]
13. Population-based organized cervical cancer screening pilot program in France.
Hamers FF; Duport N; Beltzer N
Eur J Cancer Prev; 2018 Sep; 27(5):486-492. PubMed ID: 28362653
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of cervical cancer screening in Iceland, 1964-2002: a study on trends in incidence and mortality and the effect of risk factors.
Sigurdsson K; Sigvaldason H
Acta Obstet Gynecol Scand; 2006; 85(3):343-9. PubMed ID: 16553184
[TBL] [Abstract][Full Text] [Related]
15. Cytological screening for cervical cancer in the province of Limburg, Belgium.
Arbyn M; Van Nieuwenhuyse A; Bogers J; De Jonge E; De Beeck LO; Matheï C; Buntinx F
Eur J Cancer Prev; 2011 Jan; 20(1):18-24. PubMed ID: 20805755
[TBL] [Abstract][Full Text] [Related]
16. Risk of cervical cancer subsequent to a positive screening cytology: follow-up study in Finland.
Viikki M; Pukkala E; Hakama M
Acta Obstet Gynecol Scand; 2000 Jul; 79(7):576-9. PubMed ID: 10929958
[TBL] [Abstract][Full Text] [Related]
17. [Is there a benefit to continue pap smear screening for cervical cancer after 65 years of age? A retrospective study on 53,644 women].
Meyer R; Lemay AL; Guy X; Giraud C; Mathevet P; Flori M
Bull Cancer; 2012 Apr; 99(4):409-15. PubMed ID: 22450525
[TBL] [Abstract][Full Text] [Related]
18. [The incidence of borderline and pathologic findings in young females within the scope of gynecologic-cytologic screening studies].
Neumann HG; Barten G; Barten M; Schröder M
Zentralbl Gynakol; 1989; 111(14):947-51. PubMed ID: 2800778
[TBL] [Abstract][Full Text] [Related]
19. [Mass screening for cervical cancer. A one-year registration of cervical cytological tests].
Bjørge T; Gunbjørud AB; Langmark F; Skare GB; Thoresen SO
Tidsskr Nor Laegeforen; 1994 Jan; 114(3):341-5. PubMed ID: 8191435
[TBL] [Abstract][Full Text] [Related]
20. Is it rational to start population-based cervical cancer screening at or soon after age 20? Analysis of time trends in preinvasive and invasive diseases.
Sigurdsson K; Sigvaldason H
Eur J Cancer; 2007 Mar; 43(4):769-74. PubMed ID: 17236755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
